Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Information on natalizumab (marketed as Tysabri)
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Gammaherpesvirus Infection of Human Neuronal Cells.
Enrollment complete for cannabinoid MS study
Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Hormone and immune system interactions in demyelinating disease.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
DYNACIN (MINOCYCLINE)
Neuromyelitis Optica With Onset in Childhood and Adolescence.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »